期刊文献+

Expression of Multidrug-associated Protein, P-glycoprotein, P53 and Bcl-2 Proteins in Bladder Cancer and Clinical Implication 被引量:4

Expression of Multidrug-associated Protein, P-glycoprotein, P53 and Bcl-2 Proteins in Bladder Cancer and Clinical Implication
下载PDF
导出
摘要 The expression of multidrug resistant proteins in bladder cancer and clinical implication was studied. Expression of multidrug associated protein (MRP), P glycoprotein (P gp), P53 and Bcl 2 proteins were detected by using immunohistochemical method in 40 specimens of bladder transitional cell carcinoma. The results showed that the positive rate of MRP, P gp, P53 and Bcl 2 was 52.5 %, 57.5 %, 47.5 % and 62.5 % respectively. The positive rate of MRP, P gp, P53 and Bcl 2 in the grade Ⅰ, Ⅱ and Ⅲ of tumors was 46.3 %, 38.5 %, 38.5 %, 23.1 %; 52.9 %, 39.8 %, 47.1 %, 76.4 %; 60.0 %, 80.0 %, 60.0 %, 90.0 % respectively. The positive rate of MRP, P gp, P53 and Bcl 2 in 24 primary tumor specimens was 37.5 %, 41.7 %, 33.3 %, 45.8 % and that in 16 cases in recurrent specimens receiving chemotherapy 75.0 %, 81.3 %, 68.8 %, 87.5 % respectively. It was suggested the positive rate of MRP, P gp, P53 and Bcl 2 was increased with the advance of tumor grade. The positive rate of four proteins in all recurrent cases was significantly increased ( P <0.05). The expression of MRP, P gp, P53 and Bcl 2 proteins might be the important factors for chemotherapy failure. The expression of multidrug resistant proteins in bladder cancer and clinical implication was studied. Expression of multidrug associated protein (MRP), P glycoprotein (P gp), P53 and Bcl 2 proteins were detected by using immunohistochemical method in 40 specimens of bladder transitional cell carcinoma. The results showed that the positive rate of MRP, P gp, P53 and Bcl 2 was 52.5 %, 57.5 %, 47.5 % and 62.5 % respectively. The positive rate of MRP, P gp, P53 and Bcl 2 in the grade Ⅰ, Ⅱ and Ⅲ of tumors was 46.3 %, 38.5 %, 38.5 %, 23.1 %; 52.9 %, 39.8 %, 47.1 %, 76.4 %; 60.0 %, 80.0 %, 60.0 %, 90.0 % respectively. The positive rate of MRP, P gp, P53 and Bcl 2 in 24 primary tumor specimens was 37.5 %, 41.7 %, 33.3 %, 45.8 % and that in 16 cases in recurrent specimens receiving chemotherapy 75.0 %, 81.3 %, 68.8 %, 87.5 % respectively. It was suggested the positive rate of MRP, P gp, P53 and Bcl 2 was increased with the advance of tumor grade. The positive rate of four proteins in all recurrent cases was significantly increased ( P <0.05). The expression of MRP, P gp, P53 and Bcl 2 proteins might be the important factors for chemotherapy failure.
机构地区 Department of Urology
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2001年第1期56-58,共3页 华中科技大学学报(医学英德文版)
关键词 bladder neoplasms multiple drug resistance apoptosis bladder neoplasms multiple drug resistance apoptosis
  • 相关文献

参考文献10

  • 1Miyashita T,Reed J.Bcl-2 oncoprotein blocks chemot herapy-induced apoptosis in a human leukemia cell line[].Blood.1993
  • 2Lowe S W,Ruley H E,Jacks T et al.P53-dependent apoptosis modulates the cytotoxicity of anticancer agents[].Cell.1993
  • 3Linn S C,Honkoop A H,Hoekman K et al.P53 and Pglycoprotein are often co-expressed are associated with poor prognosis in breast cancer[].British Journal of Cancer.1996
  • 4Clifford S C,Neal D E,Lunee J.Alterations in express of the multidrug resistance-associated protein ( MRP )gene in high-grade transitional carcinoma of the bladder[].British Journal of Cancer.1996
  • 5Oshika Y,Nakamura M,Tokunaga T et al.Multidrug resistance-associated protein and mutant P53 protein expression in non-small cell lung cancer[].Modern Pathology.1998
  • 6Slapak C A,Fracasso P M,Martell R L et al.Overexpression of the multidrug resistance-associated protein( MRP) gene in vincristine but not doxorubicin-selected multidrug-resistance murine erythroleukemia cells[].Cancer Research.1994
  • 7Rhodes T,Barrand M A,Twentyman P R et al.Modification by brefeldin A, bafilomycin A1, and 7-chloro-4nitrobenz-2-oxa-1, 3-diazole(NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23 R[].British Journal of Cancer.1994
  • 8Eid H,Gulyas M,Geczi L et al.Expression of Bcl-2 in testicular carcinoma: correlation with tumor progression and MDR1 pgp[].Cancer.1998
  • 9Wang Q,Beck W T.Transcripional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type P53[].Cancer Research.1998
  • 10Strauss B E,Shivakumar C,Deb S P et al.The MDR1 downstream promoter contains sequence-specific binding sites for wild-type P53[].Biochemical and Biophysical Research Communications.1995

同被引文献11

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部